4//SEC Filing
AQUINOX PHARMACEUTICALS, INC 4
Accession 0001209191-14-018962
$NGNECIK 0001404644operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 5:22 PM ET
Size
10.3 KB
Accession
0001209191-14-018962
Insider Transaction Report
Form 4
Pelzer Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2014-03-06+8,333→ 14,843 totalExercise: $11.00Exp: 2024-03-05→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest in equal annual installments, at a rate of 1/3rd of the total number of shares on the one-year anniversary of the grant date, 1/3rd of the total number of shares on the second-year anniversary of the grant date, and 1/3rd of the total number of shares on the third-year anniversary of the grant date.
- [F2]Includes (i) 8,333 shares issuable upon exercise of an option grant pursuant to the issuer's 2014 Equity Incentive Plan (the "2014 Plan") and (ii) 6,510 option securities issuable upon exercise of an option granted pursuant to the issuer's Joint Canadian Stock Option Plan (the "2006 Plan"). Each option under the 2014 Plan is exercisable for shares of common stock. Each option security granted under the 2006 Plan is exercisable for an "option security". Prior to the closing of the issuer's initial public offering, an option security is comprised of one common exchangeable share and one special voting share of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act. Following the closing of the issuer's initial public offering, an option security will be comprised of one share of the issuer's common stock.
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeoperating
Related Parties
1- filerCIK 0001404644
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 5:22 PM ET
- Size
- 10.3 KB